We are excited to be a part of the ARMI BioFabUSA program. We look forward to the collaborations to help ARMI’s mission to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.
“TheWell Bioscience Inc., a New Jersey biotech company focused on 3D cell culture, launched VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking in 2020.
3D bioprinting is an emerging technology to construct complex and physiologically relevant multicellular tissue or disease models for regenerative medicine and drug discovery. Despite its significant potential, there are tremendous challenges in cytocompatibility, printability, and adjustable mechanical properties of current bioinks for 3D scaffold fabrication and long-term cell culture. Also, the crossing methods of current bioinks rely on temperature adjustment, chemical reactions, or UV curing, which would cause cell damage during the process.”
Read more of the New Member Spotlight here: